Amiram Katz, MD, DABPN, Named a Professional of the Year in Neurology

Dr. Katz seeks a revolutionary treatment method that could help millions of patients suffering
from Alzheimer's disease and launches a device that can save thousands of lives
 

Orange, CT, October 28, 2015, Amiram Katz, Neurologist and CEO of MedAhead, Inc., has been named a Worldwide Branding Professional of the Year in Neurology. While inclusion in Worldwide Branding is an honor, only a few members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, years of service, and the credentials they have provided in association with their Worldwide Branding membership.

Dr. Katz has 40 years of professional experience, with 20 years as the CEO of MedAhead, Inc. Throughout his extensive career, he has set himself apart working in the areas of diving and hyperbaric medicine, seizure disorders and sleep medicine, Lyme disease, multiple sclerosis, as well as Alzheimer’s disease. His daily work sees him providing medical care, consultations, and research and development in these areas, as well as developing and marketing proprietary medical devices and treatments.

Presently, Dr. Katz is seeking an affordable treatment for Alzheimer’s disease, using immunoglobulin that bypass the blood-brain barrier, implementing a proprietary method and device that obviate the necessity for spinal taps and other unpleasant methods of treatment delivery. Currently, the alternative of intravenous immunoglobulin (IVIg) is prohibitively expensive, such that it is insufficient to treat even a small fraction of patients with this condition. At the same time he expects to launch his medical device FlowKeepers® in 2016, which is intended to save thousands of lives annually by preventing fatal blood clots.

Looking back, Dr. Katz attributes his clinical success to his passion for his work, "thinking out of the box" and ability to treat every patient on an individual basis. Dr. Katz takes pride in focusing on his patients needs, and providing them with the best medical outcome for their illness and conditions. He was drawn to science at an early age. During high school, Dr. Katz was inspired to become involved with people's care. The natural choice was to become a doctor, even though he wished to become a pilot and aeronautic engineer years before. Having grown up in a small village, there were no doctors in his family until he started on his path. Working on a farm with a daily need for improvisation, prepared him to be an inventor in the future.

In the coming years, Dr. Katz intends to continue to provide top-quality medical care to his patients from a practice aspect, and experience continued growth and success from a clinical research aspect with his current clinical trials in Alzheimer's and future research in treating Lyme disease.

About Worldwide Who’s Who©
With over 500,000 members representing every major industry, Worldwide Who’s Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Worldwide Who’s Who employs similar public relations techniques to those utilized by Fortune 500 companies, making them cost-effective for members who seek to take advantage of its career enhancement and business advancement services.

Worldwide Who’s Who membership provides individuals with a valuable third-party endorsement of their accomplishments, and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.

For more information, please visit http://www.worldwidewhoswho.com.

Contact:
Disclaimer: If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Worldwide Who's Who disclaims any content contained in this press release. Please see the complete Worldwide Who's Who Terms of Service for more information